Abiraterone
Total Payments
$34,599
Transactions
12
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $23,072 | 7 | 2 |
| 2022 | $11,527 | 5 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $19,849 | 6 | 57.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,150 | 2 | 29.3% |
| Honoraria | $4,000 | 1 | 11.6% |
| Food and Beverage | $600.00 | 3 | 1.7% |
Top Doctors Receiving Payments for Abiraterone
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology | Cincinnati, OH | $16,532 | 4 |
| , M.D | Medical Oncology | Houston, TX | $11,527 | 5 |
| Amer Zeidan | Hematology & Oncology | Rochester, NY | $6,540 | 3 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $34,599
Product Information
- Type Drug
- Total Payments $34,599
- Total Doctors 3
- Transactions 12
About Abiraterone
Abiraterone is a drug associated with $34,599 in payments to 3 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2022 to 2023. In 2023, $23,072 was paid across 7 transactions to 2 doctors.
The most common payment nature for Abiraterone is "Travel and Lodging" ($19,849, 57.4% of total).